Pharmaceutical Accountability Foundation

News from and about the Pharmaceutical Accountability Foundation

Recent News

The Pharmaceutical Accountability Foundations’ Excessive Pricing Case Against AbbVie Heads to Court 9 May

AMSTERDAM, THE NETHERLANDS: In February 2023, the Pharmaceutical Accountability Foundation (PAF) filed a lawsuit against AbbVie Netherlands and AbbVie Inc (globally), alleging that the company...

PAF – AbbVie Humira case comes to court May 9, 2025

Friday, May 9 (09:30-12:30), Farma ter Verantwoording and AbbVie will meet at the Amsterdam District Court, Parnassusweg 280, 1076 AV Amsterdam (near Amsterdam Zuid train...

€17m fine imposed to pharma pirate Leadiant upheld on appeal

AMSTERDAM, THE NETHERLANDS: The District Court of Rotterdam has rejected the appeal of pharmaceutical company Leadiant against the 2021 decision of the Netherlands Competition Authority...

The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira

The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to the...

PRESS RELEASE: Lawsuit against AbbVie for abuse of economic dominance and violation of human rights moves to substantive phase

AbbVie's Humira pricing policy drained up to €1.2 billion from the Dutch healthcare system AMSTERDAM, NETHERLANDS: Today the Amsterdam District Court ruled that the lawsuit filed...

The Pharmaceutical Accountability Foundation faces AbbVie in Court for the first time in its Humira pricing case

AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had abused...

Subscribe to our newsletter

Never miss an update from the Pharmaceutical Accountability Foundation!



PAF in the News

Featured, 24 February, The British Medical Journal: Sharifah Sekalala, Katrina Perehudoff et al. An intersectional human rights approach toprioritising access to COVID-19 vaccines.

 

For Journalists

Interested in writing about our work? Please get in touch at press@farmaterverantwoording.nl

News by topic